Jolt Health Inc.
JOLT
CNSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 43.65% | 291.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 43.65% | 291.91% | |||
| Operating Income | -43.65% | -291.91% | |||
| Income Before Tax | -162.63% | -75.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -162.63% | -75.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -162.63% | -75.46% | |||
| EBIT | -43.65% | -291.91% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -68.97% | -34.88% | |||
| Normalized Basic EPS | 5.63% | -162.96% | |||
| EPS Diluted | -68.97% | -34.88% | |||
| Normalized Diluted EPS | 5.63% | -162.96% | |||
| Average Basic Shares Outstanding | 55.19% | 29.35% | |||
| Average Diluted Shares Outstanding | 55.19% | 29.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||